CABA7:30 AMCabaletta Bio Reports Second Quarter 2026 Financial Results and Provides Business UpdatePresentation / Abstract • Phase 1/2EULAR 2026 presentation Mon, Jun 1, 2026cabalettabio.com
CABA7:00 AMCabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 CongressPresentation / Abstract • Phase 1/2EULAR 2026 abstract release Wed, Jun 3, 2026, 7:00 AM EDTGcabalettabio.com